Lattice Biologics Ltd.
LBLTF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 155.45% | 30.11% | 264.33% | 232.20% |
| Total Receivables | -- | -- | -58.86% | 9.74% | 9.44% |
| Inventory | -- | -- | 7.84% | -26.27% | -54.78% |
| Prepaid Expenses | -- | -- | -31.10% | -34.48% | 247.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | -97.34% | -21.62% | -13.15% | -37.68% |
|
|
|||||
| Total Current Assets | -- | -97.34% | -21.62% | -13.15% | -37.68% |
| Net Property, Plant & Equipment | -- | -- | 100.12% | 207.24% | 55.56% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -100.00% | -66.65% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -75.54% | -72.93% | 15.93% | 32.68% | -15.35% |
|
|
|||||
| Total Accounts Payable | -82.14% | -42.88% | 16.41% | 11.45% | -0.78% |
| Total Accrued Expenses | -- | -- | -28.44% | -27.08% | -38.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 16.55% | 16.54% | 82.40% |
| Total Finance Division Other Current Liabilities | -- | -- | -4.20% | 25.55% | 216.30% |
| Total Other Current Liabilities | -- | -- | -4.20% | 25.55% | 216.30% |
| Total Current Liabilities | -93.72% | -82.20% | 2.01% | 1.91% | 12.86% |
|
|
|||||
| Total Current Liabilities | -93.72% | -82.20% | 2.01% | 1.91% | 12.86% |
| Long-Term Debt | -- | -- | 81.48% | 69.58% | -53.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 272.53% | 136,100.00% | 12,488.24% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -94.56% | -76.75% | 7.70% | 9.68% | 8.51% |
|
|
|||||
| Common Stock & APIC | 6.41% | 14.49% | 14.49% | 14.49% | 7.59% |
| Retained Earnings | 38.12% | 27.21% | -10.20% | -9.03% | -12.13% |
| Treasury Stock & Other | -95.57% | -95.57% | 0.00% | 0.00% | 0.28% |
| Total Common Equity | 101.48% | 77.98% | -4.51% | -1.40% | -20.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 101.48% | 77.98% | -4.51% | -1.40% | -20.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 101.48% | 77.98% | -4.51% | -1.40% | -20.89% |
|
|
|||||